Clinical Trial Update: Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial is recruiting a hepatoprotective therapy for children and adolescents with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Ain Shams University | Conditions: Leukaemia (Acute), Acute Lymphoblastic Leukemia | Phase 4 | Status: RECRUITING